Does MIGALASTAT Cause Product distribution issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product distribution issue have been filed in association with MIGALASTAT (Galafold). This represents 1.0% of all adverse event reports for MIGALASTAT.
5
Reports of Product distribution issue with MIGALASTAT
1.0%
of all MIGALASTAT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product distribution issue From MIGALASTAT?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIGALASTAT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MIGALASTAT Cause?
Product dose omission issue (41)
Renal impairment (34)
Off label use (29)
Death (26)
Fatigue (26)
Headache (25)
Cerebrovascular accident (23)
Nausea (20)
Drug ineffective (19)
Dyspnoea (19)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which MIGALASTAT Alternatives Have Lower Product distribution issue Risk?
MIGALASTAT vs MIGLITOL
MIGALASTAT vs MIGLUSTAT
MIGALASTAT vs MILNACIPRAN
MIGALASTAT vs MILRINONE
MIGALASTAT vs MILTEFOSINE